BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11983301)

  • 1. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
    Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
    Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
    J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
    Lütjohann D; von Bergmann K
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
    Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
    Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
    J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
    Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
    Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
    Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
    Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
    Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
    Locatelli S; Lütjohann D; Schmidt HH; Otto C; Beisiegel U; von Bergmann K
    Arch Neurol; 2002 Feb; 59(2):213-6. PubMed ID: 11843691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
    Kölsch H; Lütjohann D; Jessen F; Von Bergmann K; Schmitz S; Urbach H; Maier W; Heun R
    Int J Mol Med; 2006 May; 17(5):791-4. PubMed ID: 16596262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
    Shafaati M; Solomon A; Kivipelto M; Björkhem I; Leoni V
    Neurosci Lett; 2007 Sep; 425(2):78-82. PubMed ID: 17822846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.
    Bretillon L; Sidén A; Wahlund LO; Lütjohann D; Minthon L; Crisby M; Hillert J; Groth CG; Diczfalusy U; Björkhem I
    Neurosci Lett; 2000 Oct; 293(2):87-90. PubMed ID: 11027840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.
    Popp J; Lewczuk P; Kölsch H; Meichsner S; Maier W; Kornhuber J; Jessen F; Lütjohann D
    J Neurochem; 2012 Oct; 123(2):310-6. PubMed ID: 22845771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.
    Popp J; Meichsner S; Kölsch H; Lewczuk P; Maier W; Kornhuber J; Jessen F; Lütjohann D
    Biochem Pharmacol; 2013 Jul; 86(1):37-42. PubMed ID: 23291240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
    Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease.
    Kölsch H; Lütjohann D; Jessen F; Urbach H; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2006 Feb; 113(2):231-8. PubMed ID: 15959845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis.
    Wang HL; Wang YY; Liu XG; Kuo SH; Liu N; Song QY; Wang MW
    J Alzheimers Dis; 2016; 51(1):45-55. PubMed ID: 26836015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxysterols and Alzheimer's disease.
    Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
    Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
    Zuliani G; Donnorso MP; Bosi C; Passaro A; Dalla Nora E; Zurlo A; Bonetti F; Mozzi AF; Cortese C
    BMC Neurol; 2011 Oct; 11():121. PubMed ID: 21970714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.